Serono SA

By Business Review Editor

Pharma Deals Review: Vol 2002 Issue 30 (Table of Contents)

Published: 2 Nov-2002

DOI: 10.3833/pdr.v2002.i30.985     ISSN: 1756-7874

Section: Company Profile



Serono, third largest biotech company, focuses on the discovery, development and marketing of recombinant proteins and small molecules in the fields of reproductive health for treating infertility, neurology for treating relapse of multiple sclerosis, metabolic endocrinology for treating HIV-associated wasting and growth deficiencies, autoimmune diseases, oncology, gastroenterology and rheumatology...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details